Explore JAMA Network Open’s health policy collection, including open access research about health care reform, law, and economics.
This Viewpoint proposes an array of approaches state governments might take to lower health care prices paid by private insurance, including rate setting using reference pricing; scrutiny of hospital mergers; expanding scope-of-practice laws to increase workforce; and investing in alternative payment models.
This qualitative study examines the perspectives of representatives of US Medicare Advantage plans on how their organizations can enact programs to promote social determinants of health in light of expansions offered under the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act.
This cross-sectional study uses data from the US National Survey of Accountable Care Organizations to assess the association between accountable care organization–reported care management and coordination activities and outcomes in older adults with complex needs.
This cross-sectional study examines US Medicare data to assess variations in health care costs and utilization between accountable care organization practices that rely heavily on specialty physicians and those that only use primary care physicians.
This cross-sectional study examines changes in revenues of manufacturers of drugs for treatment of hepatitis C and health care organizations after list price reductions.
This cross-sectional study investigates changes in perceptions of discrimination in health care on the basis of race/ethnicity, immigration status, and English proficiency in California from 2003 to 2017.
This cohort study identifies processes of care that are associated with reduced risk of death or recurrent stroke among patients with transient ischemic attack or nonsevere ischemic stroke.
Because a “Medicare for all” policy is likely to pay physicians and health systems much less than commercial insurance, this Viewpoint anticipates responses of the community, including an increase in service volume and billing intensity and movement of care to more highly reimbursed settings, and it suggests ways to implement the policy to minimizez financial disruptions.
In this Viewpoint, Woolhandler and Himmelstein review the potential benefits of single-payer health care reform, including savings on administrative costs and lower drug prices, and argue against partial solutions that might expand coverage without reducing costs and waste.
This study assesses whether the US Food and Drug Administration regulation to limit the sale of flavored tobacco products to age-restricted locations is adequate based on a 1-year review of violations rates in age-restricted shops.
This study assesses health outcome and self-assessment data of teenaged Latino participants in the CHAMACOS study before and after the 2016 presidential election in the United States, which ushered in new immigration policy and rhetoric.
This cohort study uses data from the US Healthy Work Place study to examine characteristics of health care organizations that are associated with clinician trust in the organization.
This population-based cohort study examines the rates of naloxone coprescription since implementation of state laws mandating coprescription for persons at risk for opioid overdose.
This cross-sectional analysis of the Disclosure UK database examines the concentration and patterns of drug company payments to health care organizations in the United Kingdom.
This Viewpoint reviews recent efforts in Ohio to regulate pharmacy benefit managers (PBMs) in response to anticompetitive practices and discusses PBM reform as a means of ensuring patient access to affordable drugs.
This ecological study evaluates whether US Medicaid expansion was associated with state-level changes in physical abuse and neglect rates among children younger than 6 years compared with states that opted out of Medicaid expansion.
This survey study investigates the availability of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 3 years after the implementation of a statewide standing order allowing pharmacies to dispense naloxone without a physician’s prescription.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: